While rescription-based therapies are effective treatments for chronic post-trauma nightmares, mechanisms of change have not yet been defined. We examined the relationship between the use of cognitive-related words in nightmare narratives and the posttraumatic cognitions inventory (PTCI) in a sample of 25 trauma-exposed individuals undergoing rescription therapy for post-trauma nightmares. In addition to exploring the relationship between different types of cognitive language use and PTCI scores, the relationship between changes in their frequency of use and posttrauma cognitions were also analyzed. We found that cognitive language use as a whole in addition to the subcategories of tentative, discrepancy, and insight words within the nightmare are significantly negatively related to baseline PTCI scores, while analytic language use was positively correlated. However, cognitive language use in the rescription did not relate to PTCI scores post-treatment. Furthermore, changes in the of use cognitive language, between the nightmare and the rescription, are significantly negatively associated with severity of posttraumatic cognitions at the post-assessment. These results demonstrate the importance of understanding cognitive language in nightmare imagery as it may relay important information about treatment outcomes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.